BARD1 Life Sciences Company
BARD1 Life Sciences Ltd is an Australian life sciences company focused on developing and commercialising non-invasive diagnostic tests
Funding Status:
IPO
Industry:
Menstrual Health
Estimated Revenue:
Less than $1M
Technology:
Biomarkers of Female Cancers
Acquisitions Number:
1
Headquarters:
Nedlands, Western Australia, Australia
Total Funding:
$18,576,901
Last Funding Date:
2021-07-23
Last Funding Type:
Post-IPO Equity
Employee Number:
11-50
Investors Number:
1
Founded Date:
01-01-1983